期刊文献+

左室主动固定电极在心脏再同步化治疗中的临床应用

Clinical Application of an Active Fixation Coronary Sinus Lead on Cardiac Resynchronization Therapy
原文传递
导出
摘要 目的:探讨左室主动固定电极在心脏再同步化治疗(cardiac resynchronization therapy,CRT)中的作用并总结其临床经验。方法:收集2008年1月至2013年1月由梅州市人民医院心内科植入CRT的患者,共56例(男34例,女22例)。根据植入冠状窦电极的不同,分为左室主动固定电极组(17例)和被动电极组(39例),观察和比较两组的手术时间、透视时间和造影剂用量。结果:左室主动固定电极组的手术时间[(61±36)min vs(143±61)min,P=0.035]和透视时间[(10±5)min vs(45±11)min,P=0.042]均较被动电极组显著缩短,而造影剂用量[(36±20)ml vs(87±46)ml,P=0.041]也较被动电极组明显减少。结论:左室主动固定电极用于心脏再同步化治疗可明显缩短手术时间,降低造影剂用量,使患者和术者均获益。 Objective: To investigate the effect of an active fixation coronary sinus lead on cardiac resynchronization therapy (CRT) and summarize the clinical experience. Methods: A total number of 56 patients (male 34, female 22)were implanted with CRT in Meizhou People's Hospital during January 2008 to January 2013. Leads were categorized into two different groups on the basis of their fixation mechanism: active fixation electrode(n=l 7)and passive electrode(n=39). The operative time, fluoroscopy time and contrast agent dosage were observed and compared between two groups. Results: The operative time[(61+ 36)rain vs (143+ 61)min,P=0.035] and fluo- roscopy time[(10+ 5)min vs (45+ 11)min,P=0.042] of active fixation electrode group were significantly shorter than those of the passive electrode group, and the contrast agent dosage [(36± 20)ml vs (87± 46)ml,P=0.041] of active fixation electrode group was markedly lower than that of the passive electrode group. Conclusion: Active fixation coronary sinus lead could significantly shorten the operation time, reduce the amount of contrast media in the CRT. Patients and surgeons were all benefit from it.
出处 《现代生物医学进展》 CAS 2013年第32期6322-6324,共3页 Progress in Modern Biomedicine
关键词 左室主动固定电极 心脏再同步化治疗 冠状窦 Active fixation coronary sinus lead Cardiac resynchronization therapy Coronary sinus
  • 相关文献

参考文献19

  • 1Hansky B, Vogt J, Gueldner H, et al. Left heart pacing-experience with several types of coronary vein leads [J]. Interv Card Electrophysiol, 2002, 6:71-75.
  • 2Leon AR, Abraham WT, Curtis AB, et al. Safety oftransvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program [J]. Am Coil Cardiol, 2005,46:2348-2356.
  • 3杨立波,贾绍斌,张华,刘志军.动态优化AV/VV间期心脏再同步治疗慢性心力衰竭的临床观察[J].心脏杂志,2011,23(1):100-102. 被引量:2
  • 4Borleffs C J, van Bommel R J, Molhoek SG, et al. Requirement for coronary sinus lead interventions and effectiveness of endovaseular replacement during long-term follow-up atter implantion of a resyn- ehronizationdeviee[J]. Europaee, 2009, 11:544-545.
  • 5Nagele H, Azizi M, Hashagen S, et al. First experience with a new active fixation coronary sinus lead[J]. Europace, 2007, 9:437-441.
  • 6Saxon LA, Olshansky B, Volosin K, et al. Influence of left ventricular lead location on out-comes in the COMPANION study [J]. J Cardio- vasc Electrophysiol,2009,20: 764-768.
  • 7Kronborg MB, Albertsen AE, Nielsen JC, et al . Long-term clinical outcome and left ventricular lead position in cardiac resynchroniza- tion therapy[J]. Europace, 2009, 11:1177-1182.
  • 8周菁,丁燕生,李康,盛琴慧,蒋捷,王禹川,史力斌.左室主动固定电极在心脏再同步治疗中的初步应用[J].中国介入心脏病学杂志,2012,20(2):87-89. 被引量:1
  • 9De Cock CC,Jessurun ER, Allaart CA, et al. Repetitive intraoperative dislocation during transvenous lead implantation: usefulness of the re- tained guidewire technique [J]. Pacing Clin Electrophysiol, 2004, 27: 1589-1593.
  • 10Nagele H, Hashagen S, Ergin M, et al. Coronary sinus lead fragmen- tation 2 years after implantation with a retained guidewire [J]. Pacing Clin Electrophysiol, 2007, 30:438-439.

二级参考文献20

  • 1Varma C, Camm AJ. Pacing for heart failure[J]. Lancet, 2001, 357(9264):1277-1283.
  • 2Cazeau S, Leclercq C, Lavergne T, et al. For the Multisite Stimulation in Cardiomyopathies (MUSTIC) study investigator. Effect of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay[J]. N Engl J Med, 2001, 344(12):873-880.
  • 3Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Multicenter InSync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure[J]. N Engl J Med, 2002, 346(24):1845-1853.
  • 4Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing and Defibrillation in heart failure(COMPANTION) Investigators. Cardiac- resynchronization therapy with or without an implantable defibrillation in advanced chronic heart failure[J]. N Engl J Med, 2004, 350(21):2140-2150.
  • 5Cleland JG, Daubert JC, Erdmann E, et al. The Cardiac resynchronization in heart failure (CARE-HF) Study Investigator. The effect of cardiac resynchronization on mortality in heart failure[J]. N Engl J Med, 2005, 352(15):1539-1549.
  • 6Auricchio A, Stellbrink C, Sack S, et al. The pacing therapies for congestive heart failure (PATH-CHF) study rationale, design, and endpoints of a prospective randomized multicenter study[J]. Am J Cardiol, 1999, 83(5B):130D-135D.
  • 7Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on mortality in heart failure[J]. N Engl J Med, 2005, 352(15):1539-1549.
  • 8Reumann M, Farina D, Miri R, et al. Computer model for the optimization of AV andiron delay in cardiac resynchronization therapy[J]. Med Boil Eng Comput, 2007, 45(9):845-854.
  • 9Baker JH 2nd, McKenzie J 3rd, Beau S, et al. Acute evaluation of programmer guided AV/PV and VV delay optimization comparing an IEGM method and echocardiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICD implants[J]. J Cardiovasc Electrophysiol, 2007, 18(2):185-191.
  • 10Saxon LA, De Marco T, Chatterjee K, et al. Chronic serum norepinephrine in dilated heart patients with the greatest sympathetic activation at baseline[J]. PACE, 2000, 22(3):830.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部